Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells

International Journal of Molecular Medicine

Volumn 35, Issue 2, 2015, Pages 367-375

  Wang, Mei ^a   Cai, Jie ^a   Huang, Feng ^a   Zhu, Mengchu ^a   Zhang, Qiang ^a   Yang, Tingting ^a   Zhang, Xu ^a   Qian, Hui ^a   Xu, Wenrong ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Gastric cancer; Human umbilical cord derived mesenchymal stem cells; Interleukin 6

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; METHYLNITRONITROSOGUANIDINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; RANTES; TUMOR NECROSIS FACTOR ALPHA; ACTA2 PROTEIN, HUMAN; ACTIN; IL6 PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMING CELL; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PHENOTYPE; STOMACH CANCER; TUMOR MICROENVIRONMENT; UMBILICAL CORD; UMBILICAL CORD DERIVED MESENCHYMAL STEM CELL; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; COCULTURE; METABOLISM; NUDE MOUSE; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; XENOGRAFT;

ACTINS; ANIMALS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; HETEROGRAFTS; HUMANS; INTERLEUKIN-6; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NF-KAPPA B; STOMACH NEOPLASMS; UMBILICAL CORD;

EID: 84919674799     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.2019     Document Type: Article

References (35)

1. Whiteside TL: The tumor microenvironment and its role in promoting tumor growth. Oncogene 27: 5904-5912, 2008.
2. Candido J and Hagemann T: Cancer-related inflammation. J Clin Immunol 33: S79-S84, 2013.
3. Landskron G, De la Fuente M, Thuwajit P, Thuwajit C and Hermoso MA: Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014: 149185, 2014.
4. Allavena P, Garlanda C, Borrello MG, Sica A and Mantovani A: Pathways connecting inflammation and cancer. Curr Opin Genet Dev 18: 3-10, 2008.
5. Yang X, Hou J, Han Z, Wang Y, Hao C, Wei L and Shi Y: One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment. Cell Biosci 3: 5, 2013.
6. Barcellos-de-Souza P, Gori V, Bambi F and Chiarugi P: Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta 1836: 321-335, 2013.
7. Cao H, Xu W, Qian H, et al: Mesenchymal stem cell-like cells derived from human gastric cancer tissues. Cancer Lett 274: 61-71, 2009.
8. Xu X, Zhang X, Wang S, et al: Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues. J Cancer Res Clin Oncol 137: 495-504, 2011.
9. Wang M, Zhao C, Shi H, et al: Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br J Cancer 110: 1199-1210, 2014.
10. Al-toub M, Almusa A, Almajed M, Al-Nbaheen M, Kassem M, Aldahmash A and Alajez NM: Pleiotropic effects of cancer cells' secreted factors on human stromal mesenchymal stem cells. Stem Cell Res Ther 4: 114, 2013.
11. Ren G, Liu Y, Zhao X, et al: Tumor resident mesenchymal stromal cells endow naïve stromal cells with tumor-promoting properties. Oncogene 33: 4016-4020, 2013.
12. Gu J, Qian H, Shen L, et al: Gastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-beta/Smad pathway. PLoS One 7: e52465, 2012.
13. Zhang Q, Wang M, Huang F, et al: H. Pylori infection-induced MSC differentiation into CAFs promotes epithelial-mesenchymal transition in gastric epithelial cells. Int J Mol Med 32: 1465-1473, 2013.
14. Yang T, Zhang X, Wang M, et al: Activation of mesenchymal stem cells by macrophages prompts human gastric cancer growth through NF-κB pathway. PLoS One 9: e97569, 2014.
15. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
16. Qi Y, Zhang M, Li H, et al: Autophagy inhibition by sustained over-production of IL-6 contributes to arsenic-induced carcinogenesis. Cancer Res 74: 3740-3752, 2014.
17. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM and Karin M: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121-124, 2007.
18. Kinoshita H, Hirata Y, Nakagawa H, et al: Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis. PLoS One 8: e60914, 2013.
19. Tsai KS, Yang SH, Lei YP, et al: Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology 141: 1046-1056, 2011.
20. Rattigan Y, Hsu JM, Mishra PJ, Glod J and Banerjee D: Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. Exp Cell Res 316: 3417-3424, 2010.
21. Sung SY, Liao CH, Wu HP, et al: Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer. PLoS One 8: e71637, 2013.
22. Qiao C, Xu W, Zhu W, et al: Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int 32: 8-15, 2008.
23. Studeny M, Marini FC, Dembinski JL, et al: Mesenchymal stem cells: potential precursors for tumor stroma and targeteddelivery vehicles for anticancer agents. J Natl Cancer Inst 96: 1593-1603, 2004.
24. Spaeth EL, Dembinski JL, Sasser AK, et al: Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4: e4992, 2009.
25. Ren G, Zhao X, Wang Y, et al: CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα. Cell Stem Cell 11: 812-824, 2012.
26. Goldstein RH, Reagan MR, Anderson K, Kaplan DL and Rosenblatt M: Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Res 70: 10044-10050, 2010.
27. Brighenti E, Calabrese C, Liguori G, Giannone FA, Trerè D, Montanaro L and Derenzini M: Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. Oncogene: Feb 17, 2014. doi: 10.1038/onc.2014.1.
28. Polanska UM and Orimo A: Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells. J Cell Physiol 228: 1651-1657, 2013.
29. Karnoub AE, Dash AB, Vo AP, et al: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563, 2007.
30. Mi Z, Bhattacharya SD, Kim VM, Guo H, Talbot LJ and Kuo PC: Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis 32: 477-487, 2011.
31. Mitra AK, Zillhardt M, Hua Y, Tiwari P, Murmann AE, Peter ME and Lengyel E: MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov 2: 1100-1108, 2012.
32. Guilloton F, Caron G, Ménard C, et al: Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes. Blood 119: 2556-2567, 2012.
33. Kulbe H, Thompson R, Wilson JL, et al: The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 67: 585-592, 2007.
34. Xue Y, Lim S, Yang Y, et al: PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells. Nat Med 18: 100-110, 2011.
35. Karin M and Greten FR: NF-kappa B: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759, 2005.